Frankfurt
15.04.26 | 08:04
0,159 Euro
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.03. | Vext Science Inc: Vext to discontinue operations at Arizona facility | 1 | Stockwatch | ||
| VEXT SCIENCE Aktie jetzt für 0€ handeln | |||||
| 30.03. | VEXT Science, Inc.: Vext Science Announces Strategic Optimization of Arizona Operations and Plans for Ohio Cultivation Expansion | 367 | Newsfile | Strategic closure and planned sale of Eloy cultivation facility expected to improve Arizona profitability and enhance free cash flow.Proceeds from the sale to facilitate debt reduction, with key... ► Artikel lesen | |
| 04.03. | Vext Science Inc: Vext receives licence for seventh dispensary in Ohio | 4 | Stockwatch | ||
| 03.03. | VEXT Science, Inc.: Vext Advances Ohio Expansion with Seventh Retail Location | 417 | Newsfile | Secures provisional dual-use license for Columbus dispensary, with operations expected to begin in Q4 2026, subject to regulatory approvals.Marks Vext's seventh dispensary in Ohio, and second in... ► Artikel lesen | |
| 02.01. | Vext Science Inc: Vext Science investor Nguyen sells 20,340 shares | 8 | Stockwatch | ||
| 11.12.25 | VEXT Science, Inc.: Vext Announces Voting Results of Annual General Meeting | 446 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - December 11, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("VEXT" or the "Company"), a U.S.-based cannabis operator with vertical operations... ► Artikel lesen | |
| 20.11.25 | VEXT Science, Inc.: Vext Reports Q3 2025 Financial Results | 1.103 | Newsfile | Vext Reports Q3 2025 Financial Results; Revenue Up 41% Year-over-Year and Operating Cash Flow Year-To-Date Reaches $8.5 Million Revenue of $12.7 million, up 41% YoY, driven by expanded Ohio retail operations... ► Artikel lesen | |
| 20.11.25 | Vext Science Inc: Vext Science has EBITDA of $2.31M (U.S.) in Q3 2025 | 4 | Stockwatch | ||
| 20.11.25 | Vext Science reports Q3 results | 4 | Seeking Alpha | ||
| 11.11.25 | Vext Science Inc: Vext Science to release Q3 2025 results Nov. 20 | 1 | Stockwatch | ||
| 11.11.25 | VEXT Science, Inc.: Vext to Announce Financial Results for Q3 2025 on November 20, 2025 | 407 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - November 11, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations... ► Artikel lesen | |
| 17.09.25 | VEXT Science, Inc.: Vext Secures State Approval for Portsmouth Dispensary Ownership Transfer | 401 | Newsfile | Upon closing, expected by October 1, 2025, Portsmouth will become Vext's fifth fully consolidated dispensary in Ohio. The Company expects to bring additional locations online through late 2025 and... ► Artikel lesen | |
| 20.08.25 | VEXT Science, Inc.: Vext Announces Q2 2025 Financial Results: Record Quarterly Revenue with Strong 31% Cash Flow Margin | 582 | Newsfile | Record financial performance, with growth in revenue, adjusted EBITDA, and operating cash flow driven by strong Ohio momentum and disciplined operations in Arizona.Revenue of $13.4 million, up 59%... ► Artikel lesen | |
| 11.08.25 | VEXT Science, Inc.: Vext to Announce Financial Results for Q2 2025 on August 20, 2025 | 388 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - August 11, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in... ► Artikel lesen | |
| 24.06.25 | VEXT Science, Inc.: Vext Continues Ohio Expansion with Sixth Dispensary Location in Fairfield | 409 | Newsfile | Secures a provisional license for sixth Ohio dispensary in Fairfield, with operations expected to begin in Q4 2025, subject to regulatory approvals.Demonstrates Vext's strategic approach to retail... ► Artikel lesen | |
| 16.06.25 | VEXT Science, Inc.: Vext Opens Fifth Ohio Dispensary in Portsmouth, Growing Retail Footprint in Key Ohio Market | 402 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - June 16, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator with vertical operations in Arizona... ► Artikel lesen | |
| 05.06.25 | VEXT Science, Inc.: Vext Announces Change of Auditor | 661 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - June 5, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona... ► Artikel lesen | |
| 21.05.25 | VEXT Science, Inc.: Vext Delivers Record Q1 Performance: Achieves $3.1 Million in Operating Cash Flow on $11.6 Million in Revenue | 539 | Newsfile | Revenue grew 38% to $11.6 million compared to $8.4 million in Q1 2024, and up 13% sequentially from $10.2 million in Q4 2024, driven by growth in Ohio.Q1 2025 operating cash flow reached $3.1 million... ► Artikel lesen | |
| 13.05.25 | VEXT Science, Inc.: Vext to Announce Financial Results for Q1 2025 on May 21, 2025 | 469 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - May 13, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 3,106 | -1,08 % | Aurora & Co. vor Höllenritt: Tilray schon durch, aber Berichtssaison könnte Cannabis-Aktien beben lassen | © Foto: adobe.stock.comDie Quartalsberichtssaison läuft an. Noch plätschert sie vergleichsweise gemächlich dahin. Zunächst stehen die US-Banken im Fokus. Doch in wenigen Tagen wird es auch im Cannabis-Sektor... ► Artikel lesen | |
| CANOPY GROWTH | 0,958 | -2,19 % | Nach den Tilray-Zahlen: Aurora, Canopy & Co. vor richtungsweisender Berichtssaison | In einer Phase, in der sich das Handelsgeschehen auf die Auswirkungen des Iran-Krieges zu konzentrieren scheint, nimmt die Quartalsberichtssaison Fahrt auf. Für die Cannabis-Unternehmen wird es möglicherweise... ► Artikel lesen | |
| TILRAY BRANDS | 5,850 | -0,85 % | Tilray Brands Inc (2): Tilray files for U.S. ATM equity sale of up to $180M | ||
| INNOCAN PHARMA | 3,910 | -1,76 % | InnoCan Pharma sendet Krisensignal: Was große Adressen heute bereits wissen - So reagieren erfahrene Anleger jetzt | ||
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | TAAT Global Alternatives Inc (2): TAAT Global CEO Saxon resigns | ||
| CRONOS GROUP | 2,270 | -1,73 % | Cronos Group Inc.: Cronos Group Reports 2025 Fourth Quarter and Full-Year Results | Net revenue in Q4 2025 increased by 47% year-over-year to $44.5 million; Net revenue in FY 2025 increased by 25% year-over-year to $146.6 million Achieved record net revenue in Q4 2025 and FY 2025... ► Artikel lesen | |
| SYNBIOTIC | 1,898 | +7,23 % | EQS-News: SYNBIOTIC SE: SYNBIOTIC startet mit operativem Fortschritt, neuen regulatorischen Impulsen und starker Branchenpräsenz ins Frühjahr 2026 | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Marktbericht/Prognose
SYNBIOTIC startet mit operativem Fortschritt, neuen regulatorischen Impulsen und starker Branchenpräsenz ins Frühjahr... ► Artikel lesen | |
| DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures Announces Resignation of Director | Vancouver, British Columbia--(Newsfile Corp. - April 8, 2026) - Digicann Ventures Ltd. (CSE: DCNN.X) ("Digicann" or the "Company"), a company focused on opportunities within and outside of the cannabis... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 1,296 | +0,31 % | Organigram Global Inc.: Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities | Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram") and Sanity Group GmbH ("Sanity" or "Sanity Group") jointly announced the successful closing of Organigram's previously... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 6,020 | +0,67 % | Green Thumb Industries Inc: Green Thumb releases social impact report | ||
| SNDL | 1,278 | -0,93 % | SNDL Inc.: SNDL to Report First Quarter 2026 Financial Results on April 29, 2026 | ||
| CRESCO LABS | 0,815 | -1,45 % | Cresco Labs Inc: Cresco Labs opens seventh dispensary in Ohio | ||
| NOVERIS HEALTH SCIENCES | 1,170 | 0,00 % | XFRA 0NF1: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNOVERIS HEALTH SCI.... ► Artikel lesen | |
| QUANTUM BIOPHARMA | 2,724 | +3,81 % | Quantum BioPharma Wins Significant Court Challenge in USD $700,000,000 Claim as Defendants Joint Motion to Dismiss Lawsuit Alleging Market Manipulation by CIBC World Markets and RBC Dominion Securities is Denied | TORONTO, April 02, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building... ► Artikel lesen | |
| HAPPY BELLY FOOD GROUP | 0,965 | 0,00 % | Happy Belly Food Group Inc.: Happy Belly Food Group's Heal Wellness Announces Grand Opening of First Quebec Location in Montreal | Toronto, Ontario--(Newsfile Corp. - April 16, 2026) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands... ► Artikel lesen |
VEXT SCIENCE INC gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,159 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VEXT SCIENCE INC finden Sie auf Wallstreet Online.